Dermatología y medicina del estilo de vida. El foco en la inflamación de bajo grado
DOI:
https://doi.org/10.47196/da.v31i3.2956Palabras clave:
medicina del estilo de vida, inflamación de bajo grado, dermatosis crónicas, bienestar integral, mirada holística, dermatología integrativa, psoriasis, dermatitis atópica, hidradenitis supurativaResumen
La medicina del estilo de vida (MEV) es un conjunto de intervenciones terapéuticas basadas en evidencia científica que busca mejorar hábitos para prevenir, tratar e incluso revertir enfermedades crónicas no transmisibles. Propone seis pilares: alimentación, ejercicio, sueño, manejo del estrés, cesación de hábitos tóxicos y conexión social.
La inflamación crónica de bajo grado activa continuamente el sistema inmunitario con niveles elevados de citocinas inflamatorias y puede conducir a las principales causas de enfermedad, morbilidad y mortalidad en todo el mundo como las enfermedades cardiovasculares y metabólicas.
En dermatología, considerar una mirada holística e integral puede ofrecer una posibilidad mayor de éxito terapéutico y alivio de los síntomas en el seguimiento de patologías crónicas, inflamatorias, oncológicas, metabólicas y autoinmunes, entre otras.
Citas
I. Fields D, Arnold M, Karlsen M, Kelly J. A lifestyle medicine approach to medication deprescribing: an introduction. J Fam Pract. 2022;71(suppl 1 Lifestyle):eS100-eS104.
II. Guthrie GE. What is lifestyle medicine? Am J LifestyleMed. 2018;12:363-364:S1-S45.
III. Calder P, Albers R, Antoine JM, Blum S, et ál. Inflammatory disease processes and interactions with nutrition. Br J Nutr. 2009;101(Suppl 1).
IV. Monteiro C. Nutrition and health. The issue is not food, nor nutrients so much as processing. Public Health Nutr. 2009;12:729-731.
V. Bulló M, Casas-Agustench P, Amigó-Correig P, Aranceta J, et ál. Inflammation, obesity and comorbidities: the role of diet. Public Health Nutr.2007;10:1164-1172.
VI. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
VII. Booth F, Roberts C, Late M. Lack of exercise is a major cause of chronic disease. Compr Physiol. 2012;2:1143-1211.
VIII. Dunstan D, Howard H, Healy GN, Owen N. Too much sitting a health hazard. Diabetes Res & Clin Pract. 2012;97:368-376.
IX. Solarz DE, Mullington JM, Meier-Ewart HK. Sleep, inflammation and cardiovascular disease. Front Biosci. 2012;4:2490-2501.
X. Puttonen S, Viitasalo K, Häarmä M. Effect of shift work on systemic markers of inflammation. ChronobiolInt. 2011;28:528-535.
XI. Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity and metabolic complications. Ann N Y Acad Sci. 2006;1083:77-110.
XII. Steiger H, Thaler L. Eating disorders, gene-environment interactions and the epigenome: roles of stress exposures and nutritional status. Physiol Behav. 2016;162:181-185.
XIII. O’Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol. 2007;50:1009-1014.
XIV. Haber PS, Riordan BC, Winter DT, Barrett L, et ál. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Med J Aust. 2021 4;215 Suppl7:S3-S32.
XV. Holt-Lunstad J, Smith TB, Layton B. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010;7:e1000316.
XVI. Ketterer M, Rose B, Knysz W, Farha A, et ál. Is social isolation/alienation confounded with, and non-independen tof, emotional distress in its association with early onset of coronary artery disease? Psychol Health Med. 2011;16:238-247.
XVII. Kiecolt-Glaser JK, Gouin JP, Hantsoo L. Close relationships, inflammation, and health. Neurosci Biobehav Rev. 2010;35:33-38.
XVIII. Furman D, Campisi J, Verdin E, Carrera-Bastos P. et ál. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25:1822-1832.
XIX. Rohleder N. Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med. 2014;76:181-189.
XX. Egger G. In search of a germ theory equivalent for chronic disease. Prev Chronic Dis. 2012;9:E95.
XXI. Vodovotz Y, Barnard N, Hu FB, JakicicJM, et ál. Prioritized research for the prevention, treatment, and reversal of chronic disease. Recommendations from the lifestyle medicine research summit. Front Med. 2020;7:585744.
XXII. León Pedroza JI, González-Tapia LA, del Olmo-Gil E, Castellanos-Rodríguez D, et ál. Inflamación sistémica de grado bajo y su relación con el desarrollo de enfermedades metabólicas de la evidencia molecular a la aplicación clínica. Cir Cir. 2015;83:543-51.
XXIII. Goh J, Goh KP, Abbasi, A. Exercise and adipose tissue macrophages. New frontiers in obesity research? Front Endocrinol. 2016;7:65.
XXIV. Reed RG, Raison CL. Stress and the immune system. Environmental Influences on the Immune System. 2016;97-126.
XXV. Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, et ál. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2023;19:275-293.
XXVI. Teixeira TF, Moreira AP, Souza NC, FriasR, et ál. Intestinal permeability measurements: general aspects and posible pitfalls. Nutrhosp. 2014;29:269-281.
XXVII. Alarcón-Burneo FR. Intestino permeable el portal de la enfermedad. Rev Cient Sal Des Hum. 2024;5:932-948.
XXVIII. Patel SR, Zhu X, Storfer-Isser A, Mehra R, et ál. Sleep duration and biomarkers of inflammation. Sleep. 2009;32:200-204.
XXIX. Park, DY, Park JY, Lee D, Hwang I, et ál. Leaky gum: the revisited origin of systemic diseases. Cells. 2022;11:1079.
XXX. Plachokova AS, Andreu-Sánchez S, Noz MP, Fu J, et ál. Oral microbiome in relation to periodontitis severity and systemic inflammation. Intl J Mol Sci. 2021;22:5876.
XXXI. Motivala SJ. Sleep and inflammation. Psychoneuroimmunology in the context of cardiovascular disease. Ann Behavl Med. 2011;42:141-152.
XXXII. Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab. 2010;24:775-784.
XXXIII. Smith KJ, Gavey J, RIddell NE, Kontari P, et ál. The association between loneliness, social isolation and inflammation: a systematic review and meta-analysis. Neurosci Biobehavi Rev. 2020;112:519-541.
XXXIV. Uchino BN, Trettevik R, Kent de Grey RG, Cronan S, et ál. Social support, social integration, and inflammatory cytokines: a meta-analysis. Health Psychol. 2018;37:462-471.
XXXV. Naldi L. Psoriasis and smoking: links and risks. Psoriasis (Auckl). 2016;6:65-71.
XXXVI. Wei L, Chen S, Zhang Z, Kuai L, et ál. Prevalence of tobacco smoking and its association with diseases everity among patients with psoriasis in China: a cross-sectional study. Front Med (Lausanne). 2022;9:883458.
XXXVII. Kearney N, Kirby B. Alcohol and psoriasis for the dermatologist: know, screen, intervene. Am J Clin Dermatol. 2022;23:881-890.
XXXVIII. Balato N, Megna M, Palmisano F, Patruno C, et ál. Psoriasis and sport: a new ally? J Eur Acad DermatolVenereol. 2015;29:515-520
XXXIX. Custurone P, Macca L, Bertino L, Di Mauro D, et ál. Mutual influence of psoriasis and sport. Medicina (Kaunas). 2021;57:161.
XL. Raszkiewicz M, et ál. Environmental risk factors and epigenetic alternations in psoriasis. Ann Agric Environ Med. 2020;27:335-342.
XLI. Musumeci M, et ál. The role of lifestyle and nutrition in psoriasis: current status of knowledge and interventions. Dermatol Ther. 2022;35:e15685.
XLII. Michalski P, et ál. A cross roads between dietaryhabits, alcohol consumption, and smoking in the clinical course of psoriasis: a narrative review. Postepy Dermatol Alergol. 2023;40(5):599-605.
XLIII. Kartha LB, et ál. Serum melatonin levels in psoriasis and associated depressive symptoms. Clin ChemLab Med. 2014;52(6):e123-125.
XLIV. Marchesi C, et ál. ¿Existe un real impacto de las alteraciones del sueño en psoriasis y dermatitis atópica? Autoinmunidad 2022;24(7):87-90.
XLV. Sahin E, et ál. Prevalence and factors associated with sleep disturbance in adult patients with psoriasis. J Eur Acad Dermatol Venereol. 2022;3 (5):688-697.
XLVI. Mrowietz U, et ál. Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation. J Eur Acad Dermatol Venereol. 2023;37:1731-1738.
XLVII. Lam K, Agrawal DK. Lifestyle factors in the clinical manifestation and management of atopic dermatitis. Arch Intern Med Res. 2025;8:25-35.
XLVIII. Mann C, Gorai S, Staubach-Renz P, Goldust M. Sleep disorders in dermatology. A comprehensive review. J Dtsch Dermatol Ges. 2023 Jun;21:577-584.
XLIX. Bawany F, Northcott CA, Beck LA, Pigeon WR. Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies. J Allergy Clin Immunol Pract.2021;9:1488-1500.
L. Chang YS, Chiang BL. Sleep disorders and atopic dermatitis. A 2-way street? J Allergy Clin Immunol. 2018;142:1033-1040.
LI. Cameron S, Donnelly A, Broderick C, Arichi T, et ál. Mind and skin: exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis. Allergy. 2024;79:26-36.
LII. Kong S, Koo J, Lim SK. Associations between stress and physical activity in Korean adolescents with atopic dermatitis based on the 2018-2019 Korea youth risk behavior web-based survey. Int J Environ Res Public Health. 2020;17:8175.
LIII. Ryguła I, Pikiewicz W, Grabarek BO, Wójcik M, Kaminiów K. The role of the gut microbiome and microbial dysbiosis in common skin diseases. Int J Mol Sci. 2024 Feb6;25:1984.
LIV. Lorite-Fuentes J, Molina-Leyva A, Cuenca-Barrales C, Arias-Santiago S. Influence of the Mediterranean diet and physical activity on hidradenitis suppurativa: a cross-sectional study. Int J Dermatol. 2022;61:1175-1182.
LV. Weber M, Gulliver W, Margesson LJ, et ál. Effects of exercise and dietary modifications on hidradenitis suppurativa: a systematic review. Am J Clin Dermatol. 2023;24:343-357.
LVI. Luo X, Ruan Z, Liu L. Causal relationship between metabolic syndrome and hidradenitis suppurativa: a two-sample bidirectional Mendelian randomization study. J Dermatol. 2024;51:1335-1349.
LVII. Krajewski PK, Matusiak Ł, Szepietowski JC. Adipokines: a link between obesity and hidradenitis suppurativa? Br J Dermatol. 2023;188:320-323.
LVIII. Jemec GBE, Hansen PR. The relationship between smoking and hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34:e294-e296.
LIX. Thorlacius L, Ingram JR, Villumsen B, et ál. Smoking cessation and risk of hidradenitis suppurativa: a population-based cohort study. JAMA Dermatol. 2024;160:67-74.
LX. Puig L, De la Cueva P, Notario J, et ál. Epigenetic regulationof circadian genes in hidradenitis suppurativa: implications for inflammation. J Eur Acad Dermatol Venereol. 2024;38:e33-e36.
LXI. Zouboulis CC, Bechara FG, Dickinson-Blok JL, et ál. Pruritus and pain as major symptoms of hidradenitis suppurativa: a prospective study. Acta Derm Venereol. 2019;99:357-362.
LXII. Gusev E, Sarapultsev A. Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci. 2023;24:7910.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2025 a nombre de los autores. Derechos de reproducción: Sociedad Argentina de Dermatología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.
Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor
